Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Last Close
Apr 16  •  04:00PM ET
35.42
Dollar change
-0.26
Percentage change
-0.73
%
Category
US Equities - Industry Sector
Asset Type
Equities (Stocks)
Tags
Return% 1Y
29.91%
Total Holdings
53
Perf Week
3.00%
Sponsor
Simplify ETF
ETF Type
Tags
Return% 3Y
12.77%
AUM
237.90M
Perf Month
4.82%
Fund Family
Bond Type
Tags
Return% 5Y
-
NAV/sh
Perf Quarter
-5.80%
Index
-
Average Maturity
Tags
-
Return% 10Y
52W High
38.68 -8.43%
Perf Half Y
7.99%
Index Weighting
Commodity Type
Tags
-
Return% SI
52W Low
27.28 29.84%
Perf YTD
-3.22%
Active/Passive
Quant Type
Tags
-
Flows% 1M
-7.79%
Volatility
1.57% 1.70%
Perf Year
26.41%
ESG Type
Tags
-
Flows% 3M
-27.48%
ATR (14)
0.66
Perf 3Y
37.25%
Dividend Type
Sector/Theme
Flows% YTD
-29.29%
RSI (14)
61.00
Perf 5Y
-
Structure Type
Region
Flows% 1Y
Beta
0.75
Perf 10Y
-
Expense
0.51%
Growth/Value
SMA20
4.87%
Flows% 3Y
Rel Volume
0.14
Prev Close
35.68
Inverse/Leveraged
Market Cap
SMA50
1.92%
Flows% 5Y
Avg Volume
150.16K
Price
35.42
IPO
Oct 08, 2021
Option/Short
Yes / Yes
SMA200
5.23%
Trades
Volume
20,966
Change
-0.73%
Mar-09-26 11:47AM
Feb-25-26 01:46AM
Feb-17-26 06:42AM
Jan-29-26 08:20AM
Jan-26-26 08:55AM
10:00AM Loading…
Nov-26-25 10:00AM
May-02-25 03:25AM
Apr-30-25 04:35AM
Apr-23-25 05:45AM
Apr-18-25 01:40PM
Apr-04-25 08:30AM
Apr-02-25 07:00AM
Apr-01-25 05:40AM
Mar-28-25 06:05AM
Mar-20-25 04:32PM
01:30PM Loading…
Feb-28-24 01:30PM
Dec-15-23 07:00PM
Oct-31-23 03:00AM
Oct-12-22 09:05AM
May-17-22 08:56AM
Dec-28-21 08:57AM
Simplify Health Care ETF seeks long-term capital appreciation. Under normal circumstances, the fund will invest at least 80% of its assets (plus any borrowings for investment purposes) in securities of U.S. health care companies. The fund adviser defines health care companies as companies included in the Global Industry Classification Standard health care sector. The fund will typically invest in 50 - 100 health care companies. The adviser generally seeks investments in companies that are developing new and effective medicines, as well as companies whose business models reduce costs or improve quality in health care systems.